Switching Antifibrotic Agents May Improve Outcomes in Idiopathic Pulmonary Fibrosis

Posted by: admin Categories: Idiopathic Pulmonary Fibrosis

The retrospective study evaluated 262 patients with IPF who received pirfenidone or nintedanib — 2 antifibrotic agents currently in use that have similar ...

Source link

« Abbott asks Texas hospitals to postpone elective procedures to free beds for latest Covid surge

Utah researchers say antibody treatment effective against COVID-19 »

Latest Tweets

Breathing+ by Breathing Labs has passed peer review in a randomized controlled clinical trial that was recently pub… twitter.com/i/web/status/15431…
July 2, 2022 11:37 am
BREAKING: @breathinglabs and @Nintendo clinical trial is published in journal Pediatric Pulmonology (SCI Q2, Impact… twitter.com/i/web/status/15404…
June 24, 2022 10:20 pm
Clinical mouthpieces 10pcs packages are now available at 45€/50USD (shipping cost not included). Learn more:… twitter.com/i/web/status/15000…
March 5, 2022 10:56 am
BREATHING VR: Lately we are sourcing this VR headset for use in Breathing VR application. It allows easiest install… twitter.com/i/web/status/13990…
May 30, 2021 3:52 pm
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be su… twitter.com/i/web/status/13328…
November 28, 2020 10:41 pm
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that… twitter.com/i/web/status/13237…
November 3, 2020 7:31 pm
Registration and all functionalities at breathinglabs.com (and in our iOS and Android games) are fixed and fu… twitter.com/i/web/status/12407…
March 19, 2020 10:50 pm
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys… twitter.com/i/web/status/11717…
September 11, 2019 12:00 pm
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial… twitter.com/i/web/status/11580…
August 4, 2019 5:55 pm

Home

How To Start

Q&A

Login

Switching Antifibrotic Agents May Improve Outcomes in Idiopathic Pulmonary Fibrosis

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE

IN MEDIA

Home

How To Start

Products

Breathing+ Package

Toys Package

Q&A

Login

Switching Antifibrotic Agents May Improve Outcomes in Idiopathic Pulmonary Fibrosis

You may also like...

Server Error in ‘/Profiles’ Application.

Analysis of tumor necrosis factor-alpha, transforming growth factor-beta, interleukin-10, IL-6, and interferon-gamma gene polymorphisms in patients with chronic periodontitis.

Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis | Dermatology | JAMA Dermatology

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE

IN MEDIA